Nanni, P., De Giovanni, C., Burocchi, A., Nicoletti, G., Landuzzi, L., Palladini, A., . . . Lollini, P. (2018). OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis. Oncoimmunology.
Citação norma ChicagoNanni, Patrizia, et al. "OX40 Triggering Concomitant to IL12-engineered Cell Vaccine Hampers the Immunoprevention of HER2/neu-driven Mammary Carcinogenesis." Oncoimmunology 2018.
Citação norma MLANanni, Patrizia, et al. "OX40 Triggering Concomitant to IL12-engineered Cell Vaccine Hampers the Immunoprevention of HER2/neu-driven Mammary Carcinogenesis." Oncoimmunology 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.